Whitehawk Therapeutics (WHWK) Change in Receivables (2016 - 2025)
Whitehawk Therapeutics (WHWK) reported Change in Receivables of $1.0 million for Q1 2025, up 280.18% year-over-year from $263033.2 in Q1 2024, and up 256.99% quarter-over-quarter from -$637000.0 in Q4 2024.
Whitehawk Therapeutics (WHWK) Change in Receivables (2016 - 2025) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 8 years of Change in Receivables data on file, last reported at $1.0 million in Q1 2025.
- Change in Receivables for Q1 2025 came in at $1.0 million, up 280.18% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.0 million (up 140.96% YoY), and the FY2025 annual result was $1.0 million, up 140.96% from the prior year.
- Change in Receivables grew to $1.0 million in Q1 2025 per WHWK's latest filing, from -$637000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $3.7 million in Q1 2023 and troughed at -$14.0 million in Q1 2021.
- A 5-year average of -$483066.7 and a median of -$120000.0 in 2021 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2022 and 2023: Change in Receivables tumbled 437.5% in 2022, then jumped 930.81% in 2023.
- A 5-year view of Change in Receivables shows it stood at -$120000.0 in 2021, then slumped by 232.5% to -$399000.0 in 2022, then jumped by 42.61% to -$229000.0 in 2023, then slumped by 178.17% to -$637000.0 in 2024, then surged by 256.99% to $1.0 million in 2025.
- Business Quant data shows WHWK's Change in Receivables at $1.0 million in Q1 2025, -$637000.0 in Q4 2024, and $620000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | -637,000.00 |
| Dec 31, 2024 | -637,000.00 |
| Sep 30, 2024 | 620,000.00 |
| Sep 30, 2024 | 620,000.00 |
| Jun 30, 2024 | 987,000.00 |
| Jun 30, 2024 | 987,000.00 |
| Mar 31, 2024 | -555,000.00 |
| Mar 31, 2024 | -555,000.00 |
| Dec 31, 2023 | -229,000.00 |
| Dec 31, 2023 | -229,000.00 |
| Sep 30, 2023 | 2.04 Mn |
| Sep 30, 2023 | 2.04 Mn |
| Jun 30, 2023 | -1.89 Mn |
| Jun 30, 2023 | -1.89 Mn |
| Mar 31, 2023 | 3.70 Mn |
| Mar 31, 2023 | 3.70 Mn |
| Dec 31, 2022 | -399,000.00 |
| Dec 31, 2022 | -399,000.00 |